Morningside Venture Investments Ltd - Net Worth and Insider Trading
Morningside Venture Investments Ltd Net Worth
The estimated net worth of Morningside Venture Investments Ltd is at least $411 Million dollars as of 2024-11-05. Morningside Venture Investments Ltd is the 10% Owner of Apellis Pharmaceuticals Inc and owns about 12,806,342 shares of Apellis Pharmaceuticals Inc (APLS) stock worth over $362 Million. Morningside Venture Investments Ltd is the 10% Owner of Amylyx Pharmaceuticals Inc and owns about 6,997,302 shares of Amylyx Pharmaceuticals Inc (AMLX) stock worth over $41 Million. Morningside Venture Investments Ltd is also the 10% Owner of GreenLight Biosciences Holdings PBC and owns about 16,919,155 shares of GreenLight Biosciences Holdings PBC (GRNA) stock worth over $5 Million. Besides these, Morningside Venture Investments Ltd also holds Kezar Life Sciences Inc (KZR) . Details can be seen in Morningside Venture Investments Ltd's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Morningside Venture Investments Ltd has not made any transactions after 2023-03-29 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Morningside Venture Investments Ltd
Morningside Venture Investments Ltd Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Morningside Venture Investments Ltd owns 7 companies in total, including Kezar Life Sciences Inc (KZR) , Apellis Pharmaceuticals Inc (APLS) , and Liquidia Corp (LQDA) among others .
Insider Ownership Summary of Morningside Venture Investments Ltd
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
KZR | Kezar Life Sciences Inc | 2023-02-06 | 10 percent owner |
APLS | Apellis Pharmaceuticals Inc | 2021-11-18 | 10 percent owner |
LQDA | Liquidia Corp | 2018-07-30 | 10 percent owner |
2014-02-06 | 10 percent owner | ||
2023-03-29 | 10 percent owner | ||
2022-08-11 | 10 percent owner | ||
2022-02-02 | 10 percent owner |
Morningside Venture Investments Ltd Latest Holdings Summary
Morningside Venture Investments Ltd currently owns a total of 4 stocks. Among these stocks, Morningside Venture Investments Ltd owns 12,806,342 shares of Apellis Pharmaceuticals Inc (APLS) as of November 18, 2021, with a value of $362 Million and a weighting of 87.94%. Morningside Venture Investments Ltd owns 6,997,302 shares of Amylyx Pharmaceuticals Inc (AMLX) as of March 29, 2023, with a value of $41 Million and a weighting of 9.86%. Morningside Venture Investments Ltd also owns 16,919,155 shares of GreenLight Biosciences Holdings PBC (GRNA) as of August 11, 2022, with a value of $5 Million and a weighting of 1.23%. The other 1 stocks Kezar Life Sciences Inc (KZR) have a combined weighting of 0.96% among all his current holdings.
Latest Holdings of Morningside Venture Investments Ltd
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
APLS | Apellis Pharmaceuticals Inc | 2021-11-18 | 12,806,342 | 28.26 | 361,843,193 |
AMLX | Amylyx Pharmaceuticals Inc | 2023-03-29 | 6,997,302 | 5.80 | 40,584,352 |
GRNA | GreenLight Biosciences Holdings PBC | 2022-08-11 | 16,919,155 | 0.30 | 5,067,287 |
KZR | Kezar Life Sciences Inc | 2023-02-06 | 544,799 | 7.27 | 3,960,689 |
Holding Weightings of Morningside Venture Investments Ltd
Morningside Venture Investments Ltd Form 4 Trading Tracker
According to the SEC Form 4 filings, Morningside Venture Investments Ltd has made a total of 2 transactions in Apellis Pharmaceuticals Inc (APLS) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Apellis Pharmaceuticals Inc is the acquisition of 250,000 shares on November 18, 2021, which cost Morningside Venture Investments Ltd around $10 Million.
According to the SEC Form 4 filings, Morningside Venture Investments Ltd has made a total of 8 transactions in Amylyx Pharmaceuticals Inc (AMLX) over the past 5 years, including 2 buys and 6 sells. The most-recent trade in Amylyx Pharmaceuticals Inc is the sale of 29,048 shares on March 29, 2023, which brought Morningside Venture Investments Ltd around $884,512.
According to the SEC Form 4 filings, Morningside Venture Investments Ltd has made a total of 1 transactions in GreenLight Biosciences Holdings PBC (GRNA) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in GreenLight Biosciences Holdings PBC is the acquisition of 3,061,224 shares on August 11, 2022, which cost Morningside Venture Investments Ltd around $12 Million.
More details on Morningside Venture Investments Ltd's insider transactions can be found in the Insider Trading History of Morningside Venture Investments Ltd table.Insider Trading History of Morningside Venture Investments Ltd
- 1
Morningside Venture Investments Ltd Trading Performance
GuruFocus tracks the stock performance after each of Morningside Venture Investments Ltd's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Morningside Venture Investments Ltd is -9.86%. GuruFocus also compares Morningside Venture Investments Ltd's trading performance to market benchmark return within the same time period. The performance of stocks bought by Morningside Venture Investments Ltd within 3 months outperforms 5 times out of 11 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Morningside Venture Investments Ltd's insider trading performs compared to the benchmark.
Performance of Morningside Venture Investments Ltd
Morningside Venture Investments Ltd Ownership Network
Ownership Network List of Morningside Venture Investments Ltd
Ownership Network Relation of Morningside Venture Investments Ltd
Morningside Venture Investments Ltd Owned Company Details
What does Kezar Life Sciences Inc do?
Who are the key executives at Kezar Life Sciences Inc?
Morningside Venture Investments Ltd is the 10 percent owner of Kezar Life Sciences Inc. Other key executives at Kezar Life Sciences Inc include Chief Business Officer Nicholas Michael Mordwinkin , 10 percent owner Equal Talent Investments Ltd , and Chief Medical Officer Noreen Henig .
Kezar Life Sciences Inc (KZR) Insider Trades Summary
Over the past 18 months, Morningside Venture Investments Ltd made no insider transaction in Kezar Life Sciences Inc (KZR). Other recent insider transactions involving Kezar Life Sciences Inc (KZR) include a net sale of 6,688 shares made by ,
In summary, during the past 3 months, insiders sold 0 shares of Kezar Life Sciences Inc (KZR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 669 shares of Kezar Life Sciences Inc (KZR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 669 shares.
Kezar Life Sciences Inc (KZR)'s detailed insider trading history can be found in Insider Trading Tracker table.
Kezar Life Sciences Inc Insider Transactions
Morningside Venture Investments Ltd Mailing Address
Above is the net worth, insider trading, and ownership report for Morningside Venture Investments Ltd. You might contact Morningside Venture Investments Ltd via mailing address: Mccarthy Legal Services, 1188 Centre Street, Newton Centre Ma 02459.